| Code | 3406A | ||||||||||
| MA number | EU/1/12/797/001 | ||||||||||
| Product Form: | sol inj 1x0,09 ml/3,6 mg (striek.inj.napl.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Bayer AG, Germany | ||||||||||
| Therapeutic Class: | 64 - OPHTHALMOLOGICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Intravitreal use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 22.11.2012 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Eylea_Prirucka pre predpisujuceho lekara.pdf
|
| Dokument: |
Eylea_Prirucka pre pacienta DEM.pdf
|
| Dokument: |
Eylea_Prirucka pre pacienta nVDPM.pdf
|
| Dokument: |
Eylea_Prirucka pre pacienta CRVO.pdf
|
| Dokument: |
Eylea_Prirucka pre pacienta mCNV.pdf
|
| Dokument: |
Eylea_Prirucka pre pacienta BRVO.pdf
|
| Safety feature | Yes |
| Data update: | 11.01.2024 |
